TNF-α and H2O2 induce IL-18 and IL-18Rβ expression in cardiomyocytes via NF-κB activation

Biochemical and Biophysical Research Communications

Volumn 303, Issue 4, 2003, Pages 1152-1158

  Chandrasekar, Bysani ^a   Colston, James T ^a   De La Rosa, Sam D ^a   Rao, Perla P ^a   Freeman, Gregory L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiomyocytes; NF B; Oxidative stress; PDTC; Proinflammatory cytokines; Reperfusion injury

Indexed keywords

CYTOKINE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; LIGAND; MESSENGER RNA; PROTEIN PRECURSOR; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; IL18RAP PROTEIN, RAT; INTERLEUKIN 18 RECEPTOR BETA; INTERLEUKIN RECEPTOR;

AGONIST; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BIOLOGY; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; HEART MUSCLE; HEART MUSCLE CELL; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SUPERNATANT; ANIMAL; BIOSYNTHESIS; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; UPREGULATION; WISTAR KYOTO RAT;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HYDROGEN PEROXIDE; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR BETA SUBUNIT; MYOCARDIUM; NF-KAPPA B; RATS; RATS, INBRED WKY; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-18; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0037453250     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00496-0     Document Type: Article

References (28)

1. Gu Y., Kuida K., Tsutsui H., Ku G., Hsiao K., Fleming M.A., Hayashi N., Higashino K., Okamura H., Nakanishi K., Kurimoto M., Tanimoto T., Flavell R.A., Sato V., Harding M.W., Livingston D.J., Su M.S. Activation of interferon-γ inducing factor mediated by interleukin-. 1β converting enzyme Science. 275:1997;206-209.
2. Dinarello C.A., Novick D., Puren A.J., Fantuzzi G., Shapiro L., Muhl H., Yoon D.Y., Reznikov L.L., Kim S.H., Rubinstein M. Overview of interleukin-18: more than an interferon-γ inducing factor. J. Leukoc. Biol. 63:1998;658-664.
3. Bazan J.F., Timans J.C., Kaselein R.A. A newly discovered interleukin-1. Nature. 379:1996;591.
4. Born T.L., Thomassen E., Bird T.A., Sims J.E. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 273:1998;29445-29450.
5. Dinarello C.A. IL-18: a TH1-inducing, proinflammatory cytokine, and new member of the IL-1 family. J. Allergy Clin. Immunol. 103:1999;11-24.
6. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9:1998;143-150.
7. Mallat Z., Henry P., Fressonnet R., Alouani S., Scoazec A., Beaufils P., Chvatchko Y., Tedgui A. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart. 88:2002;467-469.
8. Yamaoka-Tojo M., Tojo T., Inomata T., Machida Y., Osada K., Izumi T. Circulating levels of interleukin18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J. Card. Fail. 8:2002;21-27.
9. Raeburn C.D., Dinarello C.A., Zimmerman M.A., Calkins C.M., Pomerantz B.J., McIntyre R.C. Jr., Harken A.H., Meng X. Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 283:2002;H650-H657.
10. Pomerantz B.J., Reznikov L.L., Harken A.H., Dinarello C.A. Inhibition of caspase1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-. 1β Proc. Natl. Acad. Sci. USA. 98:2001;2871-2876.
11. Piper H.M., Probst I., Schwartz P.F.J., Hutter, Spieckermann P.G. Culturing of calcium stable adult cardiac myocytes. J. Mol. Cell. Cardiol. 14:1982;397-412.
12. Chandrasekar B., Smith J.B., Freeman G.L. Ischemia-reperfusion of rat myocardium activates nuclear factor-. κB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine Circulation. 103:2001;2296-2302.
13. + CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a PI3 kinase-NF- κB pathway J. Biol. Chem. 278:2003;4675-4686.
14. Wheeler R.D., Culhane A.C., Hall M.D., Pickering-Brown S., Rothwell N.J., Luheshi G.N. Detection of the interleukin 18 family in rat brain by RT-PCR. Brain Res. Mol. Brain Res. 77:2000;290-293.
15. Hedtjarn M., Leverin A.L., Eriksson K., Blomgren K., Mallard C., Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J. Neurosci. 22:2002;5910-5919.
16. Meldrum D.R. Tumor necrosis factor in the heart. Am. J. Physiol. Regul. Integr. Comp. Physiol. 274:1998;R577-R595.
17. Morel J.C.M., Park C.C., Kumar P., Koch A.E. Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NF. κB activation Lab. Invest. 81:2001;1371-1383.
18. Matsumoto S., Tsuji-Takayama K., Aizawa Y., Koide K., Takeuchi M., Ohta T., Kurimoto M. Interleukin-18 activates NF-. κB in murine T helper type 1 cells Biochem. Biophys. Res. Commun. 234:1997;454-457.
19. Kojima H., Aizawa Y., Yanai Y., Nagaoka K., Takeuchi M., Ohta T., Ikegami H., Ikeda M., Kurimoto M. An essential role for NF-. κB in IL-18-induced IFN-γ expression in KG-1 cells J. Immunol. 162:1999;5063-5069.
20. Bowie A., O'Neill L.A. Oxidative stress and nuclear factor-. κB activation: a reassessment of the evidence in the light of recent discoveries Biochem. Pharmacol. 59:2000;13-23.
21. Tone M., Thompson S.A., Tone Y., Fairchild P.J., Waldmann H. Regulation of IL-18 (IFN-γ-inducing factor) gene expression. J. Immunol. 159:1997;6156-6163.
22. Hurgin V., Novick D., Rubinstein M. The promoter of IL-18 binding protein: activation by an IFN-γ-induced complex of IFN regulatory factor1 and CCAAT/enhancer binding protein β Proc. Natl. Acad. Sci. USA. 99:2002;16957-16962.
23. Yin M., Yang S.Q., Lin H.Z., Lane M.D., Chatterjee S., Diehl A.M. Tumor necrosis factor α promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes. J. Biol. Chem. 271:1996;17974-17978.
24. Simeonova P.P., Toriumi W., Kommineni C., Erkan M., Munson A.E., Rom W.N., Luster M.I. Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species. J. Immunol. 159:1997;3921-3928.
25. Dinarello C.A. Novel targets for interleukin 18 binding protein. Ann. Rheum. Dis. 60:2001;18-24.
26. Wyman T.H., Dinarello C.A., Banerjee A., Gamboni-Robertson F., Hiester A.A., England K.M., Kelher M., Silliman C.C. Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation. J. Leukoc. Biol. 72:2002;401-409.
27. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 53:2002;31-47.
28. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11:2001;372-377.